Bank Of America Corp Lava Therapeutics Nv Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.8 - $3.37 $27,019 - $50,587	-15,011 Reduced 97.4%	400 $0
Q1 2024 May 15, 2024	BUY	$1.53 - $4.03 $23,578 - $62,106	15,411 New	15,411 $51,000
Q1 2023 May 12, 2023	BUY	$1.59 - $3.97 $51,013 - $127,373	32,084 Added 20566.67%	32,240 $53,000
Q4 2022 Feb 10, 2023	BUY	$3.37 - $7.31 $525 - $1,140	156 New	156 $0
Q1 2022 May 16, 2022	SELL	$4.28 - $6.55 $4 - $6	-1 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$4.23 - $7.77 $38,361 - $70,466	-9,069 Reduced 99.99%	1 $0
Q3 2021 Nov 15, 2021	BUY	$5.5 - $11.0 $49,885 - $99,770	9,070 New	9,070 $54,000

3.61M

32.9K

500

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $26.8M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.